- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Laura Topor Discusses Challenges of e-Prescribing Specialty Medications
Prescribers and pharmacies can encounter some unique challenges when specialty drugs are e-prescribed, but organizations like the National Council for Prescription Drug Programs are trying to make the process smoother, explained Laura Topor, president of Granada Health.
Prescribers and pharmacies can encounter some unique challenges when specialty drugs are e-prescribed, but organizations like the National Council for Prescription Drug Programs (NCPDP) are trying to make the process smoother, explained Laura Topor, president of Granada Health.
Transcript (slightly modified)
What are the challenges of e-prescribing specialty medications, and how can they be overcome?
I’ve spent a fair amount of time through NCPDP trying to improve the standard to support e-prescribing of specialty medications, and what we’ve found is there were a lot of elements on that intake or enrollment form that a specialty pharmacy has that weren’t included. They maybe would send the prescription and still be faxing the form in, so we’ve enhanced the standard, which will be available when the new regulations come out that allow us to use it, that will simplify that process. We added things like gestational age and hospice indicators and IV administration elements.
The other challenge is often because of where the product can be dispensed, and the prescriber doesn’t know that, so we’re trying to figure that piece out to make sure that the prescription gets to the right pharmacy. We’ve got some work to do there, but it’s… Who’s going to get that prior authorization? Is the right information moving? Is it going to a pharmacy; is it going to a hub? All of those components we’re trying to address in enhancing the e-prescribing transactions.
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
